Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients
- PMID: 3609757
- DOI: 10.1007/BF02175445
Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients
Abstract
Fluorescein (F) and fluorescein glucuronide (FG) were determined in the vitreous of four diabetic patients by a double-filter slit-lamp fluorophotometric technique. Determinations were performed 60-80 min after i.v. injection of fluorescein. F and FG were also determined in plasma ultrafiltrate 5, 15, 30, 60 and 120 min after injection by high-pressure liquid chromatography. The concentration of FG in the vitreous was 3 times that of F. After correction for plasma concentrations of FG higher than those of F, the penetration index of FG through the blood-retinal barrier was found to be twice the penetration index of F. This is not what would be expected if passive transport alone were involved. Accordingly, it is suggested that active transport mechanisms contribute to the movement of F and FG across the blood-retinal barrier.
Similar articles
-
Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.Graefes Arch Clin Exp Ophthalmol. 1989;227(2):114-7. doi: 10.1007/BF02169781. Graefes Arch Clin Exp Ophthalmol. 1989. PMID: 2721978
-
Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.Invest Ophthalmol Vis Sci. 1986 Jul;27(7):1107-14. Invest Ophthalmol Vis Sci. 1986. PMID: 3721789
-
Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.Exp Eye Res. 1987 Feb;44(2):209-15. doi: 10.1016/s0014-4835(87)80005-2. Exp Eye Res. 1987. PMID: 3582508
-
Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous flyorophotometry.Curr Eye Res. 2001 Sep;23(3):166-70. doi: 10.1076/ceyr.23.3.166.5461. Curr Eye Res. 2001. PMID: 11803477
-
Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.Acta Ophthalmol Suppl (1985). 1993;(211):1-52. Acta Ophthalmol Suppl (1985). 1993. PMID: 8318868 Review.
Cited by
-
Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.Pharm Res. 2008 Nov;25(11):2685-96. doi: 10.1007/s11095-008-9691-3. Epub 2008 Aug 5. Pharm Res. 2008. PMID: 18679772
-
Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.Graefes Arch Clin Exp Ophthalmol. 1989;227(2):114-7. doi: 10.1007/BF02169781. Graefes Arch Clin Exp Ophthalmol. 1989. PMID: 2721978
-
Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.Graefes Arch Clin Exp Ophthalmol. 1991;229(4):350-7. doi: 10.1007/BF00170694. Graefes Arch Clin Exp Ophthalmol. 1991. PMID: 1916323
-
Outward permeability of the blood-retinal barrier.Graefes Arch Clin Exp Ophthalmol. 1992;230(1):78-83. doi: 10.1007/BF00166767. Graefes Arch Clin Exp Ophthalmol. 1992. PMID: 1547973
-
Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.Graefes Arch Clin Exp Ophthalmol. 1990;228(6):505-9. doi: 10.1007/BF00918480. Graefes Arch Clin Exp Ophthalmol. 1990. PMID: 2265765 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical